loadpatents
name:-0.03940486907959
name:-0.048460960388184
name:-0.0097708702087402
MARFAT; Anthony Patent Filings

MARFAT; Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for MARFAT; Anthony.The latest application filed is for "oxabicycloheptane prodrugs".

Company Profile
8.45.51
  • MARFAT; Anthony - Groton CT
  • Marfat; Anthony - Mystic CT
  • Marfat; Anthony - Old Lyme CT
  • Marfat, Anthony - US
  • Marfat; Anthony - Stonington CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Oxabicycloheptane Prodrugs
App 20220235066 - KOVACH; John S. ;   et al.
2022-07-28
Oxabicycloheptane prodrugs
Grant 11,236,102 - Kovach , et al. February 1, 2
2022-02-01
Amine prodrugs of pharmaceutical compounds
Grant 11,083,711 - Marfat August 10, 2
2021-08-10
Pyridinone And Pyrimidinone Phosphates And Boronates Useful As Antibacterial Agents
App 20210017206 - Brown; Matthew Frank ;   et al.
2021-01-21
Oxabicycloheptane Prodrugs
App 20200325151 - KOVACH; John S. ;   et al.
2020-10-15
Oxabicycloheptane prodrugs
Grant 10,618,908 - Kovach , et al.
2020-04-14
Amine Prodrugs Of Pharmaceutical Compounds
App 20190365721 - Marfat; Anthony
2019-12-05
Oxabicycloheptane Prodrugs
App 20190359627 - Kovach; John S. ;   et al.
2019-11-28
Octahydrocyclopenta[c]pyrrole allosteric inhibitors of SHP2
Grant 10,435,389 - Volkmann , et al. O
2019-10-08
Hydroxynorketamine Prodrugs
App 20190256487 - Volkmann; Robert A. ;   et al.
2019-08-22
Oxabicycloheptane prodrugs
Grant 10,364,252 - Kovach , et al.
2019-07-30
Octahydrocyclopenta[c]pyrrole Allosteric Inhibitors of SHP2
App 20190077792 - Volkmann; Robert ;   et al.
2019-03-14
Compounds For Treatment Of Pain
App 20190002473 - Volkmann; Robert ;   et al.
2019-01-03
Amine Prodrugs Of Pharmaceutical Compounds
App 20180318268 - Marfat; Anthony
2018-11-08
Compounds for treatment of pain
Grant 10,072,018 - Volkmann , et al. September 11, 2
2018-09-11
Oxabicycloheptane Prodrugs
App 20180244690 - Kovach; John S. ;   et al.
2018-08-30
Prodrug derivatives of (E)-N-methyl-N-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- dro-1,8-naphthyridin-3-yl)acrylamide
Grant 10,035,813 - Partridge , et al. July 31, 2
2018-07-31
Oxabicycloheptane prodrugs
Grant 9,988,394 - Kovach , et al. June 5, 2
2018-06-05
Ganaxolone Derivatives For Treatment Of Central Nervous Systems Disorders
App 20170022245 - Volkmann; Robert A ;   et al.
2017-01-26
Oxabicycloheptane Prodrugs
App 20160333024 - KOVACH; JOHN S. ;   et al.
2016-11-17
Compounds for treatment of pain
Grant 9,487,531 - Volkmann , et al. November 8, 2
2016-11-08
Compounds For Treatment Of Pain
App 20160083393 - Volkmann; Robert ;   et al.
2016-03-24
Compounds For Treatment Of Pain
App 20160068537 - Volkmann; Robert ;   et al.
2016-03-10
N-link hydroxamic acid derivatives useful as antibacterial agents
Grant 9,180,123 - Brown , et al. November 10, 2
2015-11-10
N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents
App 20150182513 - Brown; Matthew Frank ;   et al.
2015-07-02
N-link hydroxamic acid derivatives useful as antibacterial agents
Grant 9,018,384 - Brown , et al. April 28, 2
2015-04-28
Prodrug Derivatives Of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- Dro-1,8-naphthyridin-3-yl)acrylamide
App 20150065415 - Partridge; John J. ;   et al.
2015-03-05
C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
App 20140364398 - Brown; Matthew Frank ;   et al.
2014-12-11
Prodrug derivatives of (E)-N-methyl-N-((3-M ethylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin- -3-yl)acrylamide
Grant 8,901,105 - Partridge , et al. December 2, 2
2014-12-02
N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents
App 20140343031 - Brown; Matthew Frank ;   et al.
2014-11-20
5-methyldihydromorphone Compounds For Treatment Of Pain
App 20140323416 - MARFAT; Anthony ;   et al.
2014-10-30
C-linked hydroxamic acid derivatives useful as antibacterial agents
Grant 8,853,258 - Brown , et al. October 7, 2
2014-10-07
N-link hydroxamic acid derivatives useful as antibacterial agents
Grant 8,846,933 - Brown , et al. September 30, 2
2014-09-30
N-Link Hydroxamic Acid Derivatives Useful As Antibacterial Agents
App 20140128363 - Brown; Matthew Frank ;   et al.
2014-05-08
N-linked hydroxamic acid derivatives useful as antibacterial agents
Grant 8,664,401 - Brown , et al. March 4, 2
2014-03-04
Prodrug Derivatives Of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahy- Dro-1,8-naphthyridin-3-yl)acrylamide
App 20140051666 - Partridge; John J. ;   et al.
2014-02-20
N-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
App 20120258948 - Brown; Matthew Frank ;   et al.
2012-10-11
C-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
App 20120202777 - Brown; Matthew Frank ;   et al.
2012-08-09
Substituted Heterocyclic Derivatives And Their Pharmaceutical Use And Compositions
App 20120065188 - Brickner; Steven Joseph ;   et al.
2012-03-15
Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions
App 20110092480 - Brickner; Steven Joseph ;   et al.
2011-04-21
Penem prodrugs
Grant 7,795,244 - Brighty , et al. September 14, 2
2010-09-14
Penem prodrugs
Grant 7,795,243 - Brighty , et al. September 14, 2
2010-09-14
Penem Prodrugs
App 20090042853 - BRIGHTY; Katherine E. ;   et al.
2009-02-12
Substituted Heterocyclic Derivatives And Their Pharmaceutical Use And Compositions
App 20080280879 - BRICKNER; Steven Jospeh ;   et al.
2008-11-13
Penem Prodrug
App 20080125408 - Brighty; Katherine Elizabeth ;   et al.
2008-05-29
Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
Grant 7,354,941 - Marfat , et al. April 8, 2
2008-04-08
Penem Prodrugs
App 20080009474 - BRIGHTY; Katherine E. ;   et al.
2008-01-10
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
Grant 7,250,518 - Magee , et al. July 31, 2
2007-07-31
Ether Derivatives Useful As Inhibitors Of Pde4 Isozymes
App 20070161681 - Marfat; Anthony ;   et al.
2007-07-12
Ether derivatives useful as inhibitors of PDE4 isozymes
Grant 7,183,293 - Marfat , et al. February 27, 2
2007-02-27
Beta-lactamase inhibitor prodrug
Grant 7,091,197 - Marfat , et al. August 15, 2
2006-08-15
Nicotinamide derivatives useful as PDE4 inhibitors
Grant 7,060,717 - Bailey , et al. June 13, 2
2006-06-13
Nicotinamide derivatives useful as PDE4 inhibitors
App 20060014780 - Bailey; Simon ;   et al.
2006-01-19
Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
Grant 6,953,810 - Chambers , et al. October 11, 2
2005-10-11
Nicotinamide derivatives useful as PDE4 inhibitors
Grant 6,949,573 - Bailey , et al. September 27, 2
2005-09-27
Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
Grant 6,894,041 - Marfat , et al. May 17, 2
2005-05-17
Pyrrolyl-and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
Grant 6,869,945 - Marfat , et al. March 22, 2
2005-03-22
Ether derivatives useful as inhibitors of PDE4 isozymes
App 20050049258 - Marfat, Anthony ;   et al.
2005-03-03
Beta-lactamase inhibitor prodrug
App 20050004093 - Marfat, Anthony ;   et al.
2005-01-06
Ether derivatives useful as inhibitors of PDE4 isozymes
Grant 6,828,333 - Marfat , et al. December 7, 2
2004-12-07
Nicotinamide derivatives useful as PDE4 inhibitors
App 20040224975 - Balley, Simon ;   et al.
2004-11-11
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
App 20040171798 - Magee, Thomas V. ;   et al.
2004-09-02
Beta-lactamase inhibitor prodrug
App 20040110740 - Marfat, Anthony ;   et al.
2004-06-10
Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
Grant 6,740,655 - Magee , et al. May 25, 2
2004-05-25
Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors
Grant 6,716,978 - Marfat April 6, 2
2004-04-06
Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
App 20040048903 - Chambers, Robert J. ;   et al.
2004-03-11
Nicotinamide derivatives useful as PDE4 inhibitors
App 20030220366 - Bailey, Simon ;   et al.
2003-11-27
Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
App 20030220361 - Bailey, Simon ;   et al.
2003-11-27
Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
Grant 6,649,633 - Chambers , et al. November 18, 2
2003-11-18
Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
App 20030186989 - Marfat, Anthony ;   et al.
2003-10-02
Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
App 20030186974 - Marfat, Anthony ;   et al.
2003-10-02
Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors
App 20030158189 - Marfat, Anthony
2003-08-21
Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
App 20030144300 - Magee, Thomas Victor ;   et al.
2003-07-31
Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
App 20030130254 - Marfat, Anthony ;   et al.
2003-07-10
Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
Grant 6,559,168 - Marfat , et al. May 6, 2
2003-05-06
Ether derivatives useful as inhibitors of PDE4 isozymes
App 20030027845 - Marfat, Anthony ;   et al.
2003-02-06
Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
App 20020193612 - Chambers, Robert J. ;   et al.
2002-12-19
Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
App 20020123520 - Marfat, Anthony ;   et al.
2002-09-05
Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
App 20020111495 - Magee, Thomas Victor ;   et al.
2002-08-15
Indazole bioisostere replacement of catechol in therapeutically active compounds
Grant 6,391,872 - Marfat May 21, 2
2002-05-21
Therapeutically Active Compounds Based On Indazole Bioisostere Replacement Of Catechol In Pde4 Inhibitors
App 20020058687 - MARFAT, ANTHONY
2002-05-16
Nicotinamide derivatives
Grant 6,380,218 - Marfat , et al. April 30, 2
2002-04-30
Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF)
Grant 6,262,040 - Marfat July 17, 2
2001-07-17
Substituted indazole derivatives and related compounds
Grant 6,127,398 - Marfat October 3, 2
2000-10-03
Processes and intermediates for preparing 2-fluorothiophene derivatives
Grant 6,096,901 - Marfat , et al. August 1, 2
2000-08-01
Substituted tetralins, chromans and related compounds in the treatment and related compounds in the treatment of asthma, arthritis and related diseases
Grant 5,998,451 - Eggler , et al. December 7, 1
1999-12-07
Substituted indazole derivatives
Grant 5,958,953 - Marfat September 28, 1
1999-09-28
Catechol diethers as selective PDE.sup.IV inhibitors
Grant 5,814,651 - Duplantier , et al. September 29, 1
1998-09-29
Substituted sulfonamides and related compounds in the treatment of asthma, arthritis and related diseases
Grant 5,384,318 - Eggler , et al. January 24, 1
1995-01-24
Azabenzimidazoles in the treatment of asthma, arthritis and related diseases
Grant 5,322,847 - Marfat , et al. June 21, 1
1994-06-21
Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
Grant 5,116,854 - Marfat May 26, 1
1992-05-26
Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
Grant 5,059,609 - Eggler , et al. October 22, 1
1991-10-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed